HIGHLIGHTS
- who: Joris Hemelaar from the Kyoto University, Japan have published the article: Global and Regional Estimates for Subtype-Specific Therapeutic and Prophylactic HIV-1 Vaccines: A Modeling Study, in the Journal: (JOURNAL)
- what: The authors aimed to estimate the need for subtypespecific vaccines and did not estimate the actual uptake or use, which depends on factors such as adoption time, accessibility and acceptability, which will vary by country (Marzetta et_al, 2010).
- how: The Netherlands where subtype B dominates and a bivalent subtype B/E recombinant gp120 vaccine was tested in Thailand where subtype . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.